Are there any side effects associated with increased cosentyx dosage?

How common are side effects when patients receive higher doses of Cosentyx?
Higher doses of Cosentyx (secukinumab) show the same side effect profile as standard doses in clinical studies. Upper respiratory tract infections, diarrhea, and nasopharyngitis remain the most frequently reported issues, with rates that do not rise in parallel with dose increases. Clinical trial data indicate that serious adverse events stay rare and balanced between high-dose and usual-dose groups.

What infections should patients watch for at higher doses?
Patients on elevated Cosentyx doses still need to monitor for fungal and tuberculosis reactivation risks, same as at regular doses. Data from trials covering 300 mg and 450 mg regimens confirm no meaningful increase in opportunistic infections compared with 150 mg.